Cancer Research UK Manchester Institute at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
Cancer Research UK Manchester Institute takes part in 2 sessions at FoG London 2027 in London. Its sessions centre on liquid biopsy for cancer. They cover reading cell-free DNA methylation to classify tumour subtypes and tracking both tumour and host response with multi-modal liquid biopsy.
| Organization | FoG London 2027 Attendance |
|---|---|
Cancer Research UK Manchester Institute Manchester, UK | |
University of Manchester cancer research institute, core-funded by Cancer Research UK, with work spanning tumour biology and liquid biopsy biomarkers. | Talk Thu Jan 28 11:30–12:00 From cfDNA Methylation to Molecular Subtyping: Unlocking New Signals from Liquid Biopsies How methylation marks on cell-free DNA in blood can reveal tumour biology and sort patients into subtypes, and the hurdles to clinical use. Cancer genomics & diagnostics Talk Thu Jan 28 16:10–16:40 Tracking Tumour and Host Response in Cancer Using Multi-Modal Liquid Biopsy How blood tests reading several signals from both tumour and patient DNA and RNA could track cancer, immunotherapy response and side effects. |
Find decision makers at Cancer Research UK Manchester Institute
Tell us what you sell and we’ll find the people at Cancer Research UK Manchester Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction